Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

269 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Treatment of rheumatoid arthritis: state of the art 2009.
van Vollenhoven RF. van Vollenhoven RF. Nat Rev Rheumatol. 2009 Oct;5(10):531-41. doi: 10.1038/nrrheum.2009.182. Nat Rev Rheumatol. 2009. PMID: 19798027 Review.
Rheumatoid arthritis. Designing and implementing a treatment plan.
Gremillion RB, van Vollenhoven RF. Gremillion RB, et al. Postgrad Med. 1998 Feb;103(2):103-6, 110, 116-8 passim. doi: 10.3810/pgm.1998.02.314. Postgrad Med. 1998. PMID: 9479310 Review.
Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors.
Berg L, Lampa J, Rogberg S, van Vollenhoven R, Klareskog L. Berg L, et al. Ann Rheum Dis. 2001 Feb;60(2):133-9. doi: 10.1136/ard.60.2.133. Ann Rheum Dis. 2001. PMID: 11156546 Free PMC article.
[Blockade of TNFalpha--new therapeutic principle in severe rheumatoid arthritis].
Larsson P, Bratt J, Harju A, van Vollenhoven R, Klareskog L. Larsson P, et al. Lakartidningen. 2001 Feb 21;98(8):828-31. Lakartidningen. 2001. PMID: 11265568 Review. Swedish.
Dehydroepiandrosterone for the treatment of systemic lupus erythematosus.
van Vollenhoven RF. van Vollenhoven RF. Expert Opin Pharmacother. 2002 Jan;3(1):23-31. doi: 10.1517/14656566.3.1.23. Expert Opin Pharmacother. 2002. PMID: 11772330 Review.
Allele and antigen-specific treatment of rheumatoid arthritis: a double blind, placebo controlled phase 1 trial.
Kavanaugh A, Genovese M, Baughman J, Kivitz A, Bulpitt K, Olsen N, Weisman M, Matteson E, Furst D, van Vollenhoven R, Anderson J, Cohen S, Wei N, Meijerink J, Jacobs C, Mocci S. Kavanaugh A, et al. J Rheumatol. 2003 Mar;30(3):449-54. J Rheumatol. 2003. PMID: 12610799 Clinical Trial.
Clinical responses to tumor necrosis factor alpha antagonists do not show a bimodal distribution: data from the Stockholm tumor necrosis factor alpha followup registry.
van Vollenhoven RF, Klareskog L. van Vollenhoven RF, et al. Arthritis Rheum. 2003 Jun;48(6):1500-3. doi: 10.1002/art.11027. Arthritis Rheum. 2003. PMID: 12794816
Treatment with infliximab (Remicade) when etanercept (Enbrel) has failed or vice versa: data from the STURE registry showing that switching tumour necrosis factor alpha blockers can make sense.
van Vollenhoven R, Harju A, Brannemark S, Klareskog L. van Vollenhoven R, et al. Ann Rheum Dis. 2003 Dec;62(12):1195-8. doi: 10.1136/ard.2003.009589. Ann Rheum Dis. 2003. PMID: 14644858 Free PMC article.
269 results
Jump to page
Feedback